| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/22/2011 | WO2011114353A1 Monovalent human anti-hepatitis a virus antibody and uses thereof |
| 09/22/2011 | WO2011114320A1 Photoluminescent analyte partial volume probe set |
| 09/22/2011 | WO2011114287A2 Molecular markers for urinary tract infections |
| 09/22/2011 | WO2011114255A1 Method for determining the ripeness of a mango with a view to harvesting same |
| 09/22/2011 | WO2011114207A2 Comparative genomic hybridization array method for preimplantation genetic screening |
| 09/22/2011 | WO2011114150A1 Flc as biomarker |
| 09/22/2011 | WO2011114146A1 Method for detection of inflammation in the urinary tract or urethra |
| 09/22/2011 | WO2011114145A1 Detection of overtraining syndrome in an individual |
| 09/22/2011 | WO2011114139A1 Auto-antigen biomarkers for prostate cancer |
| 09/22/2011 | WO2011114044A1 Method and device for characterizing sensory properties of fabrics |
| 09/22/2011 | WO2011113953A1 In vitro process for the quick determination of a patient's status relating to infection with mycobacterium tuberculosis |
| 09/22/2011 | WO2011113942A2 Method for predicting the responsiveness to chemotherapy |
| 09/22/2011 | WO2011113935A1 Biosensor on thin-film transistors |
| 09/22/2011 | WO2011113905A1 Method for staging myocardial infarction and for monitoring efficacy of intervention |
| 09/22/2011 | WO2011113895A2 Characterization and validation of inhibitors and ligands of dipeptidyl aminopeptidase iv (dp iv) |
| 09/22/2011 | WO2011113891A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 09/22/2011 | WO2011113890A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 09/22/2011 | WO2011113888A1 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 09/22/2011 | WO2011113882A1 Diagnosis and treatment of cancer based on avl9 |
| 09/22/2011 | WO2011113869A1 Canine astrovirus astv strain bari/08 identified in dogs with gastro-enteritis |
| 09/22/2011 | WO2011113813A2 Assay |
| 09/22/2011 | WO2011113671A1 Apparatus for aligning tablets |
| 09/22/2011 | WO2011113569A1 Device and method for manipulating or analysing a liquid sample |
| 09/22/2011 | WO2011113508A1 Multi-well plate having filter medium and use thereof |
| 09/22/2011 | WO2011113160A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
| 09/22/2011 | WO2011092504A3 Biomarkers for schizophrenia |
| 09/22/2011 | WO2011091113A3 Detection of early-stage pancreatic adenocarcinoma |
| 09/22/2011 | WO2011089453A3 Mass spectrometry-based protein identification |
| 09/22/2011 | WO2011088288A8 Hybridoma cell lines and monoclonal antibodies recognizing anthrose saccharide of bacillus anthracis |
| 09/22/2011 | WO2011071935A3 Methods for diagnosing and assessing risk of developing glomerulosclerosis |
| 09/22/2011 | WO2011060374A3 Method, kit or diagnostic for the detection of reagents which induce altered contractility |
| 09/22/2011 | WO2011058123A3 Metal sputtered monofilament or multifilament hppe yarns |
| 09/22/2011 | WO2011057229A3 Fluorescent analogs of neurotransmitters, compositions containing the same and methods of using the same |
| 09/22/2011 | WO2011057078A3 Compositions and methods for detecting plectin-1 as a biomarker for cancer |
| 09/22/2011 | WO2011057063A3 Compositions and methods for quantitatively monitoring lipids |
| 09/22/2011 | WO2011053944A3 Gfp mutagenesis amplification: use of a flourescence-antibiotic resistance fusion dual reporter construct to provide quantitative and highly sensitive detection of mutations |
| 09/22/2011 | WO2011053845A3 Microvessels, microparticles, and methods of manufacturing and using the same |
| 09/22/2011 | WO2011050366A3 Methods for changing densities on non-target particles of a suspension |
| 09/22/2011 | WO2011049822A3 Patterned chemical sensor having inert occluding layer |
| 09/22/2011 | WO2011047023A3 Enhanced microplate configurations |
| 09/22/2011 | WO2011046624A3 Triangulation of pavement deflections using more than four sensors |
| 09/22/2011 | WO2011042027A3 Multiplex quantitation of individual recombinant proteins in a mixture by signature peptides and mass spectrometry |
| 09/22/2011 | WO2011041725A3 Schizophrenia treatment response biomarkers |
| 09/22/2011 | WO2011031833A3 Human anti-cancer antibodies |
| 09/22/2011 | US20110231166 Systems and methods for constructing genomic-based phenotypic models |
| 09/22/2011 | US20110231141 System and methods for processing analyte sensor data |
| 09/22/2011 | US20110231108 Protein structure analysis |
| 09/22/2011 | US20110231107 Transcutaneous analyte sensor |
| 09/22/2011 | US20110231105 Residual Compensation Including Underfill Error |
| 09/22/2011 | US20110231104 System and method for targeting relevant research activity in response to angiogenic regulator analyses |
| 09/22/2011 | US20110230761 Method and composition for hyperthermally treating cells |
| 09/22/2011 | US20110230735 Analyte sensor apparatuses having improved electrode configurations and methods for making and using them |
| 09/22/2011 | US20110230519 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | US20110230506 Predictive marker for egfr inhibitor treatment |
| 09/22/2011 | US20110230469 Method to Determine the Risk for Side Effects of an SSRI Treatment in a Person |
| 09/22/2011 | US20110230453 Use of Female Mammal's Urine for Determination of Fetal Gender Related Characteristics |
| 09/22/2011 | US20110230442 Na channels, disease, and related assays and compositions |
| 09/22/2011 | US20110230413 Predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| 09/22/2011 | US20110230392 Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor |
| 09/22/2011 | US20110230372 Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and outcome prediction in pediatric b-precursor acute lymphoblastic leukemia |
| 09/22/2011 | US20110230366 Genetic Variants Useful for Risk Assessment of Thyroid Cancer |
| 09/22/2011 | US20110230365 Mutations Associated With Cystic Fibrosis |
| 09/22/2011 | US20110230364 Methods for identifying modulators of apoptosis |
| 09/22/2011 | US20110230360 Methods for stratifying and annotating cancer drug treament options |
| 09/22/2011 | US20110229984 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 09/22/2011 | US20110229983 Marking fuel for authentication |
| 09/22/2011 | US20110229982 Method for binding a protein consisting of protein a or consisting of at least one domain of the a to e domains of the protein a to the substrate |
| 09/22/2011 | US20110229981 Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways |
| 09/22/2011 | US20110229980 Oligonucleotide probe and use thereof |
| 09/22/2011 | US20110229979 Risperidone immunoassay |
| 09/22/2011 | US20110229975 Hybridization Compositions and Methods |
| 09/22/2011 | US20110229973 Congeneric, chlorinated, brominated and/or iodised, fluorinated aromatic compounds comprising two benzol rings in their basic structure, method for their production and use thereof |
| 09/22/2011 | US20110229920 Screening methods for identifying specific staphylococcus aureus inhibitors |
| 09/22/2011 | US20110229918 Method of Quantifying Transient Interactions Between Proteins |
| 09/22/2011 | US20110229915 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 09/22/2011 | US20110229914 Use of Antibody Secreting Cell Elispot To Assess Antibody Responses Following Antigen Exposure |
| 09/22/2011 | US20110229913 Method for Amplification of Signal in Immunochromatographic Assay and Immunochromatographic Kit Using the Method |
| 09/22/2011 | US20110229912 Anti-preproprotein and anti-preprotein antibodies as immunohistochemical markers |
| 09/22/2011 | US20110229911 Azurophilic granule proteases as markers in cardiological diseases |
| 09/22/2011 | US20110229910 Fluorescent Substrates for Neurotransmitter Transporters |
| 09/22/2011 | US20110229909 RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies |
| 09/22/2011 | US20110229908 Methods and products for measuring free immunoglobulin light chain molecules |
| 09/22/2011 | US20110229907 Use of cardiac hormones to assess risk of cardiovascular complication from volume overload |
| 09/22/2011 | US20110229905 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases rlated to beclin-1 |
| 09/22/2011 | US20110229895 Method for diagnosing polycystic kidney disease |
| 09/22/2011 | US20110229892 Method for predicting a patient's responsiveness to anti-folate therapy |
| 09/22/2011 | US20110229890 Egfr mutations |
| 09/22/2011 | US20110229887 Detection of nucleic acid amplification products in the presence of an internal control sequence on an immunochromatographic strip |
| 09/22/2011 | US20110229886 Methods for detecting aneuploidy using microparticle multiplex detection |
| 09/22/2011 | US20110229885 Methods and Compositions for Determining Predisposition to Inflammation-Mediated Cardiovascular Disease |
| 09/22/2011 | US20110229875 Method of measuring human cyp3a inducibility |
| 09/22/2011 | US20110229874 Compositions and methods useful for hcv infection |
| 09/22/2011 | US20110229552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN |
| 09/22/2011 | US20110229531 Anti-protozoa compounds |
| 09/22/2011 | US20110229522 Methods, compositions and vaccines relating to neisseria meningitidis antibodies |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229495 Methods for predicting development of auto-immune diseases and treatment of same |
| 09/22/2011 | US20110229494 Teneurin and cancer |
| 09/22/2011 | US20110229491 Minichromosome maintenance complex interacting protein involved in cancer |